学术成绩与实践入门里程碑之间的关联在合作教育PharmD计划中的合作
Ali Syed1, Yuying Huang2, Joslin Goh2
1School of Pharmacy, University of Waterloo, 10 Victoria St S A, Kitchener, ON N2G 1C5, Canada.
Pharmacy (Basel, Switzerland)
|June 26, 2024
概括
学生在药房课程中的表现,特别是在合作社环境中,影响了进入实践的成功. 早期识别有风险的学生可以改善里程碑的结果,如加拿大药学考试委员会考试.
科学领域:
- 药房 教育 教育 药房 教育
- 健康 职业 教育 教育 专业
- 药剂师执照 药剂师执照 药剂师执照
背景情况:
- 关于加拿大药房合作社计划及其与进入实践的里程碑联系的研究有限.
- 合作 (合作社) 药房教育提供了超越直接患者护理的多样化经验.
研究的目的:
- 分析水loo大学药学博士 (PharmD) 合作项目中学生学业表现和评估之间的关联.
- 确定学生的成绩与进入实践的里程碑上的成功之间的关系,包括加拿大药房考试委员会 (PEBC) 药剂师资格考试和临床轮换.
主要方法:
- 收集了课程的成绩和评估,合作社的工作条款,临床轮换,以及来自三个毕业队伍的PEBC考试数据.
- 采用多重回归分析来探索学生评估与PEBC药剂师资格考试和临床轮换中的表现之间的关联.
主要成果:
- 解剖学/生理学成绩与PEBC考试成绩有负相关;专业实践课程成绩有正相关.
- 在治疗课程,第一次合作期和直接患者护理合作期的更高成绩预测了更好的临床轮换性能.
- 较低的合作社评级 (好或以下) 与课程,评估,欧安组织和PEBC措施中的更高失败率有关.
结论:
- 确定了在最后一年临床轮换和PEBC药剂师资格考试中的表现的多种预测因素.
- 预测模型可以识别有低绩效风险的学生,从而实现早期干预和课程改进.
相关概念视频
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
01:15Drug Concentration Versus Time Correlation
721
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
721
01:26Drug Administration and Therapy Phases: Overview
446
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
446
01:10Pharmacokinetics: Overview
6.2K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
6.2K
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:11Guidelines for Writing Outcome
2.7K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.7K